NCT00603109View on ClinicalTrials.gov

Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome

PHASE3TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Prader-willi Syndrome
Interventions
DRUG

rimonabant

rimonabant capsule 20 mg per day PO for 6 months

DRUG

placebo

Subjects take 20 mg placebo capsule one a day PO for 6 months

Trial Locations (1)

10065

New York Presbyterian Hospital-Weill Cornell Medical College, New York

Sponsors

Collaborators (1)

PWSAUSA
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

PWSAUSA

UNKNOWN

lead

Weill Medical College of Cornell University

OTHER